Status:
RECRUITING
Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters
Lead Sponsor:
Medstar Health Research Institute
Collaborating Sponsors:
Children's National Research Institute
Conditions:
Neurogenic Bladder
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The objectives of the proposed research among this population are: 1) to define clinically meaningful change (i.e. differentiating states of health and illness) with respect to urinary symptoms, urine...
Detailed Description
Urinary tract infection (UTI) is the most common outpatient infection world-wide, and for people with spinal cord injury (SCI) and neurogenic bladder (NB), it is the most common infection, secondary c...
Eligibility Criteria
Inclusion
- Neurogenic bladder for at least 6 months;
- Utilizing indwelling catheterization for bladder management;
- Women must be premenopausal and not currently menstruating;
- Community dwelling
- physical disability
Exclusion
- Use of prophylactic antibiotics;
- Instillation of intravesical antimicrobials to prevent UTI;
- Psychologic or psychiatric conditions influencing the ability to follow instructions;
- Use of oral or IV antibiotics within the past 2 weeks;
- Sexual activity within the previous 72 hours;
- Participation in another study with which results could be confounded.
Key Trial Info
Start Date :
January 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
182 Patients enrolled
Trial Details
Trial ID
NCT04323735
Start Date
January 10 2020
End Date
September 1 2026
Last Update
October 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MedStar National Rehabilitation Hospital
Washington D.C., District of Columbia, United States, 20010